Welcome

Pfizer Covid Vaccine Faces Hurdles After FDA Filing Friday (2)

Nov. 20, 2020, 10:28 PM

Pfizer Inc. and BioNTech SE requested emergency authorization of their Covid vaccine on Friday, and it could take at least three weeks for a U.S. Food and Drug Administration decision as trial data is probed by agency staff and outside advisers.

Shown to be 95% effective and without any major safety issues, their vaccine could be the first to be cleared for use, but first it must undergo a thorough vetting. The filing could enable its use by the middle to the end of December, the companies said in a statement.

A key step along the way is a meeting ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.